DAFTAR PUSTAKA
1. Leppert P, Fouany M, Segars JH. Understanding Uterine Fibroids.
In: Gynecology in Practice. Wiley-Blackwell, Oxford. 2013
2. Bulun SE. Uterine Fibroids, mechanisms of disease. N engl j med
2013; 369(14): 1344-55
3. Medikare V, Kandukuri LR, Ananthapur V, Deenadayal M, Nallari P.
The Genetic Bases of Uterine Fibroids; A Review. J Reprod Infertil.
2011;12(3):181-191
4. Wiknjosastro H, Saifuddin AB, Rachimhadhi T. Ilmu Kandungan.
Edisi II. PT. Bina Pustaka Sarwono Prawirohardjo. Jakarta. 2008:
73 – 90; 338 – 345.
5. Pratiwi L, Suparman E, Wagey F. Hubungan Usia Reproduksi
Dengan Kejadian Mioma Uteri Di RSUP. Prof. Dr. R.D. Kandou
Manado. Jurnal e-CliniC (eCl). 2013;1(1): 26-30
6. Ginting LY, Rasmaliah, Jemadi. Karakteristik Penderita Mioma
Uteri Yang Di Rawat Inap Di RSUD dr. Pirngadi Medan Tahun
2009-2011. Fakultas Kesehatan Masyarakat Universitas Sumatera
Utara. 2012
7. Northington GM, Arya LA. Uterine Leiomyoma. Obstetric and
Gynecology Board Review Manual. 2006;10: 1-12
8. Sozen I, Arici TA. Cellular Biology of Myomas: Interaction of Sex
Steroids with Cytokines and Growth Factors. Obstet Gynecol Clin N
Am. 2006;33: 41– 58
9. Ikbal MN.Prevalensi Anemia Pada Penderita Mioma Uteri di RSUP H. Adam Malik Medan Tahun 2010. Karya Tulis Ilmiah. Fakultas
Kedokteran Universitas Sumatera Utara. 2011
10. Villanova FE, Andrade PM, Otsuka AY, Gomes MTV, Leal ES, et al.
Estrogen receptor alpha polymorphism and susceptibility to uterine
leiomyoma. Steroids. 2006;71:960–965
11. Ciarmela P, Islam S, Reis FM, Gray PC, Bloise E, et al.Growth
possible clinical implications. Human Reproduction Update,
2011;17(6): 772–790
12. Flake GP, Andersen J, Dixon D. Etiology and Pathogenesis of
Uterine Leiomyomas: A Review. Environ Health Perspect. 2003;
111(8):1037–1054
13. Sankaran S, Manyonda IT. Medical management of fibroids. Best
Practice & Research Clinical Obstetrics and Gynaecology.
2008;4(22):655–676
14. Wango EO, Tabifor HN, Muchiri LW, Kigondu CS, Makawiti DW.
Progesterone, Estradiol And Their Respective Receptors In
Leiomyoma And Adjacent Normal Myometria of Black Kenyan
Women. African Journal of Health Sciences. 2002;3-4(9): 123-28
15. Englund K, Blanck A, Gustavsson I, Lundkvist U, Sjoblom P, et al.
Sex Steroid Receptors in Human Myometrium and Fibroids:
Changes during the Menstrual Cycle and Gonadotropin-Releasing
Hormone Treatment. J Clin Endocrinol Metab. 1998;83:4092–4096
16. Benassayag C, Leroy MJ, Rigourd V, Robert B, Honore JC, et al.
Estrogen receptors (ERalpha/ERbeta) in normal and pathological
growth of the human myometrium: pregnancy and leiomyoma. Am J
Physiol, 1999;276:E1112–E1118.
17. Bakas P, Liapis A, Vlahopoulos S, Giner M, Logotheti S, et al.
Estrogen receptor a and b in uterine fibroids: a basis for altered
estrogen responsiveness. Fertility and Sterility, 2008;3(2):1-8
18. Grings AO, Lora V, Ferreira GD, Brum IS, Corleta HE, et al. Protein
Expression of Estrogen Receptors α and β and Aromatase in Myometrium and Uterine Leiomyoma. Gynecol Obstet Invest.
2012;73:113–117
19. Nisolle M, Gillerot S, Casanas-Roux F, Squifflet J, Berliere M, et al.
Immunohistochemical study of the proliferation index, oestrogen
receptors and progesterone receptors A and B in leiomyomata and
gonadotrophin-releasing hormone agonist therapy. Human
Reproduction, 1999;14(11):2844-2850
20. Hodge JC, Morton CC. Uterine Leiomyomata : Aspects in
Reproduction, Susceptibility, abd Tumor Cytogenetics. Madame
Curie Report, Landes Bioscience. 2005
21. Payson M, Leppert P, Segars J. Epidemiology of Myomas. Obstet
Gynecol Clin N Am, 2006;33: 1-11
22. Speroff L, Fritz, MA. The Uterus. In: Clinical Gynecologic
Endocrinology and Infertility. 8th ed. Lippincott Williams & Wilkins.
North Carolina. 2011: 148-55
23. Gibs RS, Karlan BY, Haney AF, Nygaard IE. Danforth’s Obstetrics
and Gynecologic. 10th Ed. Lippincolt Williams and Wilkins. 2008 :
1003 – 6; 917 – 929.
24. Davis PC, et all. Sonohysterographic Findings of Endometrial and
Subendometrial Conditions. 2002;4(22):10-16
25. Schorge JO, Schaffler JI, Halvorson LM, Hoffman BL, Bradshaw
KD, et all. Williams gynecology. 1st Ed. McGraw-Hill Companies.
2008.
26. DeCherney AH, Nathan L. Goodwin TM, Laufer N. Current
Diagnosis and Treatements in Obstetrics and Gynecology : Benign
Disorders of the Uterine Corpus. 10th Ed. McGraw-Hill. 2007.
27. Lumsden MA. Dewhurts Text book of Obstetrics and Gynaecology :
Benign disease of the uterus. 7th Ed. Blackwell publishing.
Massachusetts, 2007: 636 – 644.
28. Katz VL. Benign Gynecologic Lesions : Vulva, Vagina, Cervix,
Uterus, Oviduct, Ovary. In: Comprehensive Gynecology, 5th ed.
Mosby Elsevier Inc. 2007
29. Speroff L, Fritz, MA. Hormone Biosynthesis, Metabolisme, and
Mechanism of Action. In: Clinical Gynecologic Endocrinology and
Infertility. 8th ed. Lippincott Williams & Wilkins. North Carolina. 2011:
30. Maruo T, Ohara N, Wang J, Matsuo H. Sex steroidal regulation of
uterine leiomyoma growth and apoptosis. Human Reproduction
Update, 2004; 3(10): 207-220
31. Ellmann S, Sticht H, Thiel F, Beckmann MW, Strick R, et al.
Estrogen and progesterone receptors: from molecular structures to
clinical targets. Cell. Mol. Life Sci. (2009) 66:2405–2426
32. Hermon TL, Moore AB, Yu L, Kissling GE, Castora FJ, et al.
Estrogen receptor alpha (ER-α) phospho-serine-118 is highly expressed in human uterine leiomyomas compared to mathed
myometrium. Virchow Arch 2008; 453: 557 – 569
33. Prabin S, Isha S, KaoruK. Immunohistochemistry: A Review of
Practical Procedure.Nepal Journal of Neuroscience 2009; 6:38-41
34. Lee A. Immunohistochemistry for Oestrogen and Progesterone
Receptors. Connection, 2008:31-33
35. Allred C. Assessment of Prognostic and Predictive Factors in
Breast Cancer by Immunohistochemistry. Connection 9, 2006:4-5
36. Kim EH, Kim JY, Lee YH, Chong GO, Park JY, et al. Comparison of
estrogen receptor-α, progesterone receptor and calponin expression in gonadotrophin-releasing hormone agonist-sensitive
and -resistant uterine fibroids. Obstet Gynecol Sci.
2014;57(2):144-150
37. Dako. ER/PR PharmDx Interpretation Manual. Nov
2007;28252:1-23
38. Lessl M, Klotzbuecher M, Schoen S, Reles A, Stockemann K, et al.
Comparative Messenger Ribonucleic Acid Analysis of Immediate
Early Genes and Sex Steroid Receptors in Human Leiomyoma and
Healthy Myometrium. J Clin Endocrinol Metab, 1997; 82: 2596–
2600
39. Barbosa LF. Epidemiological factors associated with Uterine
40. Gowri M, Mala G, Murthy S, Nayak V. Clinicopathological study of
uterine leiomyomas in hysterectomy specimens. Journal of
Evolution of Medical and Dental Sciences 2013; 2(46):9002-9009
41. Ofori EK, Asante M, Antwi WK, Coleman J, Brakohiapa EK, et al.
Relationship Between Obesity And Leiomyomas Among Ghanaian
Women. Journal of Medical and Applied Biosciences. 2012;4:14-25
42. Olotu, EJ, Osunwoke EA, Ugboma HA, Odu, KN. Age prevalence of
uterine fibroids in south-southern Nigeria: A retrospective study.
Scientific Research and Essay 2008;3(9):457-459
43. Zimmermann A, Bernuit D, Gerlinger C, Schaefers M, Geppert K.
Prevalence, symptoms and management of uterine fibroids: an
international internet-based survey of 21,746 women. BMC
Women’s Health 2012;12(6):1-12
44. Wibowo MW. Gambaran Hiperplasia Endometrium pada Kasus
Mioma Uteri di RSUP H. Adam Malik Medan. Tesis. Departemen
Obstetri dan Ginekologi Fakultas Kedokteran Universitas Sumatera
Utara. 2013
45. He Y, Zeng Q, Dong S, Qin L, Li G, et al. Associations between
uterine fibroids and lifestyles including diet, physical activity and
stress: a case-control study in China. Asia Pac J Clin Nutr
2013;22(1):109-117-109
46. Chen CR, Buck GM, Courey NG, Perez KM, Wende JW. Risk
factors for uterine fibroids among woman undergoing tubal
sterilization. A merican Journal of Epidemiology 2001; 153(1):20-26
47. Parker WH. Etiology, Symptomatology, and Diagnosis
of Uterine Myomas. Fertility and Sterility 2007;87(4):725
48. Ibrar F, Riaz S, Dawood NS, Jabeen A. Frequency Of Fibroid
Uterus In Multipara Women In A Tertiary Care Centre In
Rawalpindi. J Ayub Med Coll Abbottabad 2010;22(3);155-157
49. Lee EJ, Bajracharya P, Lee DM, Cho KH, Kim KJ, et al. Gene
and Their Estrogen Responsiveness In Vitro. The Korean Journal of
Pathology 2010; 44: 272-83
50. Asada H, Yamagata Y, Taketani T, Matsuoka A, Tamura H, et al.
Potential link between estrogen receptor-a gene hypomethylation
and uterine fibroid formation. Molecular Human Reproduction
2008;14(9):539–545
51. Yin P, Lin Z, Cheng YH, Marsh EE, Utsunomiya H, et al.
Progesterone Receptor Regulates Bcl-2 Gene Expression through
Direct Binding to Its Promoter Region in Uterine Leiomyoma Cells.
The Journal of Clinical Endocrinology & Metabolism
2007;92(11):4459–4466
52. Garget CE, Bucak K, Zaitseva M, Chu S, Taylor N, et al. Estrogen
receptor-α and –β expression in microvascular endothelial cells and smooth muscle cells of myometrium and leiomyoma. Molecular
Human Reproduction. 2002;8(8):770-775.
